NasdaqCM:RWLK

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions. More Details


Snowflake Analysis

Adequate balance sheet with limited growth.


Similar Companies

Share Price & News

How has ReWalk Robotics's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: RWLK's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-11.3%

RWLK

-1.7%

US Medical Equipment

-0.8%

US Market


1 Year Return

-64.9%

RWLK

16.5%

US Medical Equipment

13.8%

US Market

Return vs Industry: RWLK underperformed the US Medical Equipment industry which returned 16.5% over the past year.

Return vs Market: RWLK underperformed the US Market which returned 13.8% over the past year.


Shareholder returns

RWLKIndustryMarket
7 Day-11.3%-1.7%-0.8%
30 Day-5.9%-3.5%-5.7%
90 Day-39.0%12.2%8.6%
1 Year-64.9%-64.9%17.5%16.5%16.4%13.8%
3 Year-97.1%-97.1%70.0%65.6%36.9%27.8%
5 Year-99.5%-99.5%139.5%121.3%85.0%64.2%

Price Volatility Vs. Market

How volatile is ReWalk Robotics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is ReWalk Robotics undervalued compared to its fair value and its price relative to the market?

1.28x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate RWLK's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate RWLK's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: RWLK is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.

PE vs Market: RWLK is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate RWLK's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: RWLK is good value based on its PB Ratio (1.3x) compared to the US Medical Equipment industry average (3.9x).


Next Steps

Future Growth

How is ReWalk Robotics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

25.7%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: RWLK is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: RWLK is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: RWLK is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: RWLK's revenue (54.4% per year) is forecast to grow faster than the US market (9.9% per year).

High Growth Revenue: RWLK's revenue (54.4% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if RWLK's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has ReWalk Robotics performed over the past 5 years?

11.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: RWLK is currently unprofitable.

Growing Profit Margin: RWLK is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: RWLK is unprofitable, but has reduced losses over the past 5 years at a rate of 11.8% per year.

Accelerating Growth: Unable to compare RWLK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RWLK is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.8%).


Return on Equity

High ROE: RWLK has a negative Return on Equity (-114.79%), as it is currently unprofitable.


Next Steps

Financial Health

How is ReWalk Robotics's financial position?


Financial Position Analysis

Short Term Liabilities: RWLK's short term assets ($19.7M) exceed its short term liabilities ($8.8M).

Long Term Liabilities: RWLK's short term assets ($19.7M) exceed its long term liabilities ($2.0M).


Debt to Equity History and Analysis

Debt Level: RWLK's debt to equity ratio (40.1%) is considered high.

Reducing Debt: Insufficient data to determine if RWLK's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RWLK has sufficient cash runway for 12 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: RWLK is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.


Next Steps

Dividend

What is ReWalk Robotics's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate RWLK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate RWLK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if RWLK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if RWLK's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of RWLK's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.8yrs

Average management tenure


CEO

Larry Jasinski (63 yo)

8.58yrs

Tenure

US$553,512

Compensation

Mr. Lawrence J. Jasinski, also known as Larry, BS, MBA has been the Chief Executive Officer of ReWalk Robotics Ltd. (formerly Argo Medical Technologies) since February 12, 2012. From 2005 to 2012, Mr. Jasi ...


CEO Compensation Analysis

Compensation vs Market: Larry's total compensation ($USD553.51K) is about average for companies of similar size in the US market ($USD604.44K).

Compensation vs Earnings: Larry's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Lawrence Jasinski
CEO & Director8.58yrsUS$553.51k0.025%
$ 5.1k
Ori Gon
Chief Financial Officer2.58yrsUS$276.84k0.013%
$ 2.7k
Miri Pariente
Vice President of QA & Operations3.58yrsno datano data
Andy Dolan
Vice President of Marketing & Reimbursement2.5yrsno datano data
Judy Kula
Vice President of Customer Service2.5yrsno datano data
Ami Kraft
Executive Advisor to the CEO2.92yrsUS$310.00kno data

2.8yrs

Average Tenure

53yo

Average Age

Experienced Management: RWLK's management team is considered experienced (2.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lawrence Jasinski
CEO & Director8.58yrsUS$553.51k0.025%
$ 5.1k
Wayne Weisman
Independent Director11.67yrsUS$25.00k0.030%
$ 6.2k
John Poduska
Independent Director6yrsUS$73.95k0.030%
$ 6.2k
Jeffrey Dykan
Independent Chairman of the Board11.67yrsUS$25.00k0.011%
$ 2.3k
Yohanan Engelhardt
Independent Director2.33yrsUS$70.31k0.030%
$ 6.2k
Aryeh Dan
Independent Director7.67yrsUS$25.00k0.030%
$ 6.2k
Yasushi Ichiki
Independent Director6.67yrsUS$25.00k0.030%
$ 6.2k

7.7yrs

Average Tenure

62yo

Average Age

Experienced Board: RWLK's board of directors are considered experienced (7.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 162.8%.


Top Shareholders

Company Information

ReWalk Robotics Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ReWalk Robotics Ltd.
  • Ticker: RWLK
  • Exchange: NasdaqCM
  • Founded: 2001
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$20.561m
  • Shares outstanding: 19.16m
  • Website: https://www.rewalk.com

Number of Employees


Location

  • ReWalk Robotics Ltd.
  • 3 Hatnufa Street
  • 6th Floor
  • Yokneam Illit
  • 2069203
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RWLKNasdaqCM (Nasdaq Capital Market)YesOrdinary SharesUSUSDSep 2014
2RWDB (Deutsche Boerse AG)YesOrdinary SharesDEEURSep 2014

Biography

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions. It offers ReWalk Personal f ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/28 06:02
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.